S&P 500 Dividend Aristocrats: Top 5 Among Hedge Funds

2. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 84

Johnson & Johnson (NYSE:JNJ) is mainly known for developing pharmaceuticals, medical devices, and other consumer goods. In the fourth quarter of 2022, the company reported revenue of $23.7 billion, which fell by 4.4% from the same period last year. However, for FY22, its sales showed a 1.3% year-over-year growth to $94.9 billion. These sales were massively driven by strong commercial execution.

Johnson & Johnson (NYSE:JNJ) offers a quarterly dividend of $1.13 per share and has a dividend yield of 2.91%, as of February 24. The company holds one of the longest dividend growth streaks of 61 years in the US market.

Johnson & Johnson (NYSE:JNJ) was a part of 84 hedge fund portfolios in Q4 2022, as per Insider Monkey’s database. The stakes owned by these hedge funds have a total value of over $5.5 billion.